-
What is the evidence that GLP-1 medications such as Ozempic and Mounjaro might help treat addiction?
Medical Mythbusting Commentary for March 9, 2026 Source:What to know about how GLP-1 medications such as Ozempic and Mounjaro might fight addiction Reference:Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
-
GLP-1 receptor agonist lixisenatide may help slow the progression of Parkinson’s symptoms
Medical Mythbusting Commentary for April 10, 2024 Source:Ozempic-like drug may help slow the progression of Parkinson’s symptoms Reference:Trial of Lixisenatide in Early Parkinson’s Disease